Drug Shortage Report for NAT-ERLOTINIB
Report ID | 129536 |
Drug Identification Number | 02483912 |
Brand name | NAT-ERLOTINIB |
Common or Proper name | Erlotinib Hydrochloride Tablets |
Company Name | NATCO PHARMA (CANADA) INC |
Market Status | MARKETED |
Active Ingredient(s) | ERLOTINIB |
Strength(s) | 25MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | Bottle of 30's |
ATC code | L01XE |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2020-12-01 |
Actual start date | 2020-12-01 |
Estimated end date | 2025-06-30 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-02-02 |
Company comments | Long Term Backorder |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2000 ARGENTIA ROAD, PLAZA 1, SUITE 200 MISSISSAUGA, ONTARIO CANADA L5N 1P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2024-02-02 | French | Compare |
v7 | 2024-02-02 | English | Compare |
v6 | 2023-05-03 | French | Compare |
v5 | 2023-05-03 | English | Compare |
v4 | 2022-01-17 | French | Compare |
v3 | 2022-01-17 | English | Compare |
v2 | 2020-12-03 | French | Compare |
v1 | 2020-12-03 | English | Compare |
Showing 1 to 8 of 8